Abstract:To the Editor: In human and other mammals, the zona pellucida (ZP) is a glycoprotein matrix surrounding oocyte, and is vital for oogenesis, fertilization, and preimplantation development. Humans have four genetic loci encoding ZP1, ZP2, ZP3, and ZP4, and they assemble to form the insoluble ZP. In contrast to mice, human ZP1 is essential for zona pellucida matrix formation, and its variants may lead to oocyte maturation defect and female infertility. Although the development of assisted reproductive technology has benefited millions of families in the past years, total fertilization failure is still a recurrent problem for 5% to 10% of routine in vitro fertilization (IVF) cycles, with defective sperm-zona binding and penetration being a major cause. We report novel ZP1 pathogenic variants identified in an infertile 32-year-old woman with 100% zona-free oocytes, who had undergone two failed IVF cycles 5 years before. Whole exome sequencing and variant analysis showed that the patient carried a single compound heterozygous mutation in ZP1 (NM_207341:c.A1100G:p.D367G and NM_207341:c.1215delG: p.L405fs), which was detected to be transmitted from her parents (Figure 1). Protein alignments showed that the two variants were highly conserved among different species and were predicted to be deleterious by software predictions (Figure 1). Three-dimensional structure of ZP1 protein was constructed by de novo modeling techniques. It can be seen from Figure 1 that the conserved region of ZP1 is mainly composed of ß-sheet (blue part), where the mutation residue Asp367 and L405fs are located in. Obviously, Asp367 mutating to glycine may disturb the surrounding hydrogen bonds, affecting the overall structure of the ZP1 conserved region. L405fs mutation directly leads to distinct change in the ZP1 protein structure, resulting in ZP domain incomplete and C-terminal absent. To further investigate the effects of ZP1 pathogenic variants on intracellular trafficking of the ZP proteins, wild-type and mutant (D367G) expression plasmids from human-encoding ZP1 fusion protein were transfected into Hela cells. Confocal fluorescent microscopy images showed that both ZP1 proteins showed diffuse staining in the cytoplasm, while mutant ZP1 protein showed increased concentration (Figure 1). The results indicate that D367G mutation in ZP1 protein might result in intracellular sequestration and aggregation of the ZP1 protein, leading to fertilization failure. The developmental potential of the zona-free oocytes is reported to be similar to the zona intact oocytes in terms of fertilization, culture, and pregnancy outcomes. In view of her previous abnormal fertilization experience, we treated the patient by intracytoplasmic sperm injection (ICSI). After two cycles of egg retrievals, one zona-free oocyte was obtained and it was inseminated successfully with ICSI. Monitored under the time-lapse imaging system, the fertilized zygote developed into 6BC embryo and was cryopreservation. After another failed egg retrieval, frozen-thawed embryo transfer was performed and the patient delivered a healthy baby by scheduled cesarean at 38 weeks of gestation. Our findings broaden the spectrum of genetic causes and pathogenic mechanisms of infertility and should facilitate diagnosis of oocyte-borne gamete interaction defects as well as promote therapeutic development.

Pregnancy with Oocytes Characterized by Narrow Perivitelline Space and Heterogeneous Zona Pellucida: is Intracytoplasmic Sperm Injection Necessary?

The Embryological Characteristics and Clinical Outcomes of Oocytes with Indented Zona Pellucida

Effects of Abnormal Zona Pellucida on Fertilization and Pregnancy in IVF/ICSI-ET

Fertilization Results and Clinical Outcome of Oocyte with Abnormal Zona Pellucida in IVF-ET

Novel ZP1 Pathogenic Variants Identified in an Infertile Patient and a Successful Live Birth Following ICSI Treatment

Clinical analysis of the way of in vitro fertilization for patients with low oocytes retrieved

Fertilization of in Vitro Matured Human Oocytes by Intracytoplasmic Sperm Injection （ICSI） Using Ejaculated and Testicular Spermatozoa

Oocytes With A Dark Zona Pellucida Demonstrate Lower Fertilization, Implantation And Clinical Pregnancy Rates In Ivf/Icsi Cycles

Embryological Characteristics of Human Oocytes With Agar-Like Zona Pellucida and Its Clinical Treatment Strategy

Comparison of Clinical Outcomes Between Conventional in Vitro Fertilization and Intracytoplasmic Sperm Injection in Low Oocyte Retrieval Cycles

Effects of fertilization methods on pregnancy outcomes in extremely low oocyte retrieval cycles

The influence of oocyte maturation on embryo development and clinical outcomes in intracytoplasmicsperm injection cycles

Comparison of IVF Outcomes Using Conventional Insemination and ICSI in Ovarian Cycles in Which Only One or Two Oocytes Are Obtained

Effect of Fertilization Mode, the Woman's Age, Reproductive History and Numbers of Retrieved Oocytes on Abnormal Fertilization in Human IVF/ICSI

Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes through repeated oocyte retrievals could obtain reasonable cumulative pregnancy outcomes following frozen-embryo transfer

#244 : Reproductive Outcomes of Conventional in Vitro Fertilization and Intracytoplasmic Sperm Injection in Patients with Non-Severe Male Infertility Across Poor and Different Suboptimal Ovarian Response Categories

Can Sperm-Injected In-Vitro Matured (IVM) Oocytes Produce Viable Pregnancies?

The Effects of In Vitro Maturation in Rescue Treatment for Poor Ovarian Responders in In Vitro Fertilization

Higher Abnormal Fertilization, Higher Cleavage Rate, and Higher Arrested Embryos Rate Were Found in Conventional Ivf Than in Intracytoplasmic Sperm Injection

Could the presence and proportion of three/multiple pronuclei (3PN/MPN) zygotes indicate the cytoplasmic maturation state of oocyte cohort in conventional IVF patients?